What is the recommended dosage and administration protocol for intravenous (IV) magnesium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Magnesium Dosing and Administration

For most acute indications, administer 1-2 g IV magnesium sulfate over 15 minutes, with specific dosing protocols varying by clinical condition. 1, 2

Dosing by Clinical Indication

Torsades de Pointes / Polymorphic VT with QT Prolongation

  • Administer 1-2 g IV over 15 minutes 1, 3
  • This is first-line therapy regardless of serum magnesium level 3
  • Have calcium chloride immediately available to reverse potential magnesium toxicity 1

Severe Preeclampsia / Eclampsia

  • Loading dose: 4-6 g IV over 20-30 minutes 3, 2
  • Maintenance: 1-2 g/hour continuous infusion 3, 2
  • Alternative regimen: 4-5 g IV in 250 mL fluid infused simultaneously with 10 g IM (5 g in each buttock), then 4-5 g IM every 4 hours 2
  • Continue for 24 hours postpartum as the standard recommendation 3
  • Alternative approach: May discontinue after 8 g predelivery in select populations, though this requires consideration of local eclampsia incidence 3
  • Research demonstrates 1 g/hour maintenance is as effective as 2 g/hour with fewer side effects 4
  • Target therapeutic level: 1.8-3.0 mmol/L (approximately 4.3-7.2 mg/dL) 5

Severe Refractory Asthma

  • Administer 2 g IV over 20 minutes 1, 3
  • Must dilute to 20% or less concentration 2
  • Evidence shows this reduces hospital admissions by approximately 7 per 100 patients treated 6
  • Administer after oxygen, nebulized beta-agonists, and IV corticosteroids 6

Acute Hypomagnesemia

  • Mild deficiency: 1 g (8.12 mEq) IM every 6 hours for 4 doses 2
  • Severe deficiency: 5 g (40 mEq) in 1 liter fluid IV over 3 hours 2
  • Alternative for severe cases: up to 250 mg/kg IM over 4 hours if necessary 2

Pediatric Dosing

  • Hypomagnesemia/Torsades with pulses: 25-50 mg/kg (maximum 2 g) over 10-20 minutes 1
  • Pulseless torsades: 25-50 mg/kg (maximum 2 g) by bolus 1
  • Status asthmaticus: 25-50 mg/kg (maximum 2 g) over 15-30 minutes 1

Administration Rate and Safety

Maximum Infusion Rate

  • Generally do not exceed 150 mg/minute (1.5 mL of 10% solution) 2
  • Exception: severe eclampsia with active seizures may require faster administration 2
  • Rapid infusion causes hypotension and bradycardia 1

Concentration Requirements

  • Dilute to 20% or less concentration for IV infusion 2
  • Common diluents: 5% dextrose or 0.9% sodium chloride 2
  • For IM injection in children, dilute 50% solution to 20% or less 1

Maximum Daily Dosing

  • Do not exceed 30-40 g total in 24 hours 2
  • In severe renal insufficiency: maximum 20 g per 48 hours 2
  • Do not continue beyond 5-7 days in pregnancy due to risk of fetal abnormalities 2

Monitoring Requirements

Clinical Monitoring

  • Check deep tendon reflexes (patellar) before each dose 2, 5
  • Loss of patellar reflex occurs at 3.5-5 mmol/L and signals impending toxicity 5
  • Monitor respiratory rate continuously 2
  • Respiratory paralysis occurs at 5-6.5 mmol/L 5
  • Monitor urine output 2

Laboratory Monitoring

  • Obtain serum magnesium levels with frequent or prolonged dosing 1
  • Particularly critical in patients with impaired renal function 1
  • Cardiac conduction alterations occur above 7.5 mmol/L 5
  • Cardiac arrest expected when concentrations exceed 12.5 mmol/L 5

Critical Safety Considerations

Contraindications and Precautions

  • Exercise extreme caution in renal insufficiency 2
  • Monitor for common side effects: flushing, hypotension, bradycardia, CNS toxicity, respiratory depression 1, 6
  • Have calcium chloride (20 mg/kg or 0.2 mL/kg of 10% solution) immediately available as antidote 1

Drug-Specific Warnings

  • Do not mix with vasoactive amines or calcium 1
  • Magnesium is a cofactor controlling sodium and potassium transport, affecting multiple cellular processes 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.